MGX vs ACTU
Comparison between Metagenomi Inc (MGX, Company) and Actuate Therapeutics Inc (ACTU, Company).
Both MGX and ACTU are from the Healthcare sector.
MGX vs ACTU - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
MGX
$46M
ACTU
$46M
Max Drawdown
MGX
90.20%
Winner
ACTU
85.55%
Sharpe Ratio
Winner
MGX
-0.00
ACTU
-1.23
5Y Beta
MGX
1.00
ACTU
N/A
Industry
MGX
Biotechnology
ACTU
Biotechnology
P/E Ratio
MGX
-0.54
Winner
ACTU
-2.04
PEG Ratio
MGX
-0.06
ACTU
N/A
Debt to Equity
MGX
0.00%
ACTU
0.00%
Free Cash Flow Yield
MGX
N/A
ACTU
-42.40%
P/S Ratio
MGX
2.07
ACTU
N/A
P/B Ratio
MGX
0.34
ACTU
N/A
MGX vs ACTU - Historical Returns
Returns include dividend reinvestment.
1M
Winner
MGX
-11.11%
ACTU
-30.10%
3M
MGX
-23.57%
Winner
ACTU
-20.78%
6M
Winner
MGX
-27.27%
ACTU
-73.14%
1Y
Winner
MGX
-17.24%
ACTU
-76.54%
Max(CAGR)
MGX
-60.14%
Winner
ACTU
-54.74%
MGX vs ACTU - Annual Returns (2024 - 2026)
Returns include dividend reinvestment.
| Year | MGX | ACTU |
|---|---|---|
| 2026 | -28.14% | -66.50% |
| 2025 | -57.26% | -23.12% |
| 2024 | -64.99% | -7.55% |
MGX vs ACTU Drawdown Comparison
The maximum drawdown for MGX was -90.20%, occurring on Jun 12, 2026. This drawdown has not yet recovered.
The maximum drawdown for ACTU was -85.55%, occurring on Apr 10, 2026. This drawdown has not yet recovered.
The current MGX drawdown is -90.20%. The current ACTU drawdown is -83.03%.
| Rank | MGX | ACTU |
|---|---|---|
| #1 | -90.20% Feb 14, 2024 - Jun 12, 2026 | -85.55% May 30, 2025 - Apr 10, 2026 |
| #2 | N/A | -40.82% Jan 23, 2025 - May 30, 2025 |
| #3 | N/A | -36.61% Aug 14, 2024 - Oct 28, 2024 |
| #4 | N/A | -26.65% Oct 28, 2024 - Jan 21, 2025 |
Correlation
Correlation between MGX and ACTU is 0.51 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.51
-101
Select Stocks to Compare
Popular: MGX vs SPYACTU vs SPY
More Comparisons
Compare with similar stocks